A Single Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of RBD1016
Clinical trial NCT04685564 · COMPLETED
Trial details
- NCT number
- NCT04685564
- Sponsor
- Suzhou Ribo Life Science Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-05
- Primary completion
- 2021-09-08
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.